The Canadian Blood Services Research Ethics Board (REB) reviews all research involving human participants conducted by or on behalf of Canadian Blood Services, including all research involving personal information or biologic materials collected by Canadian Blood Services.
The REB ensures that research involving the participation of humans meets current research ethics standards. The REB also advises Canadian Blood Services on bioethical issues inherent in the research reviewed.
WHAT WOULD YOU LIKE TO DO?
Submit a new application
The application forms to submit a study for review by Canadian Blood Services are available below. Note that different forms are available depending on the nature of the study. Review the Frequently Asked Questions or contact CBSREB@blood.ca for assistance in completing the application form.
Investigators are required to notify Canadian Blood Services REB of any modifications to their approved studies. Modifications must first be approved by Canadian Blood Services REB before changes can be implemented unless subject safety is at risk. Modifications include Principal, Co-Investigator, or Primary Contact changes.
Canadian Blood Services REB approvals are granted for a period of one year and must be renewed on an annual basis. A maximum of four renewals may be granted (i.e., for an overall study period of five years).
Investigators are required to report immediately to Canadian Blood Services REB all serious adverse events occuring to a research participant enrolled in their studies. Incidental findings and minor adverse events must be reported within seven days.